Correction: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
Authors:
Ali S. Khashan; Marie Evans; Marius Kublickas; Fergus P. McCarthy; Louise C. Kenny; Peter Stenvinkel; Tony Fitzgerald; Karolina Kublickiene
Published in the journal:
Correction: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. PLoS Med 16(10): e32767. doi:10.1371/journal.pmed.1002977
Category:
Correction
doi:
https://doi.org/10.1371/journal.pmed.1002977
In the Funding section, the following information was inadvertently omitted: Additional funding to KK from the Swedish Research Council grant no. 2018–00932. The full funding statement should read:
The study was partly funded by the Irish Centre for Fetal and Neonatal Translational Research (INFANT) (grant no. 12/RC/2272), Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council grant No 2009–1068), the Stockholm County Council (ALF), and the Swedish Kidney Foundation. Additional funding to KK from the Swedish Research Council grant no. 2018–00932. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Zdroje
1. Khashan AS, Evans M, Kublickas M, McCarthy FP, Kenny LC, Stenvinkel P, et al. (2019) Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study. PLoS Med 16(7): e1002875. https://doi.org/10.1371/journal.pmed.1002875 31361741
Štítky
Interní lékařstvíČlánek vyšel v časopise
PLOS Medicine
2019 Číslo 10
- Příznivý vliv Armolipidu Plus na hladinu cholesterolu a zánětlivé parametry u pacientů s chronickým subklinickým zánětem
- Berberin: přírodní hypolipidemikum se slibnými výsledky
- Armolipid Plus – doplněk stravy s potvrzeným účinkem na dyslipidemii
- Nutraceutika a jejich ovlivnění mírného kardiometabolického rizika
- Nutraceutický účinek Armolipidu Plus ve snižování celkového a LDL cholesterolu u jedinců s mírnou až středně závažnou dyslipidemií
Nejčtenější v tomto čísle
- Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysis
- Association of preterm birth with lipid disorders in early adulthood: A Swedish cohort study
- Preconception diabetes mellitus and adverse pregnancy outcomes in over 6.4 million women: A population-based cohort study in China
- mHealth intervention “ImTeCHO” to improve delivery of maternal, neonatal, and child care services—A cluster-randomized trial in tribal areas of Gujarat, India